Altasciences’ preclinical experts have developed an extensive resource library to guide you through safety assessments for both small molecules and biologics.
Webinars:
 |
Downsized Miniature Swine: A New Spin on the Oldest Model Discover the increasing body of evidence that supports the use of miniature swine as a viable option for your small molecule and biologics studies. |
 |
Navigating the Challenges of Early Drug Development—How to Avoid Common Pitfalls What you need to know before starting a drug development program—with supporting case studies. |
 |
Case Studies Adversity Level Determination in Nonclinical Toxicity Studies How to interpret data on toxicity studies to classify adverse versus non-adverse effects. |
The Altascientist—A Scientific Journal:
 |
A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies How, with the increase of historical data and wider regulatory acceptance, the miniature swine model can support a variety of research areas. |
 |
Safety Pharmacology Guidelines and Practices—a Review How to save time and reduce the number of research models on study, all while ensuring the quality of your data. |
 |
Navigating the IND Submission Process Tips for planning your preclinical assessments in support of a successful regulatory submission—including when to initiate discussions with a CRO. |
eBook:
 |
Nonclinical Assessment Planning Guide Our guide will help you navigate the regulatory process and identify key milestones to get your drug to the people who need it, faster. |
 |
Scratching the Surface of Dermal Testing Learn more about our nonclinical dermal testing solutions, including the applications of miniature swine in this therapeutic area. |
We can accelerate the development of your molecules by up to 40%, from lead identification to clinical POC.
 |
 |